DOMA Perpetual, which said it owns about 7.1% of Pacira’s common shares, nominated three director candidates for the board: Christopher Dennis, Oliver Benton Curtis and Eric de Armas. DOMA said the stock is down 56% over the last decade and down 68% over the last five years. It also called for CEO Frank Lee to be replaced and for the board to name an interim CEO. DOMA urged the board to engage bankers and run a sale process for the company.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacira Biosciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202603111306PR_NEWS_USPR_____FL08024) on March 11, 2026, and is solely responsible for the information contained therein.
Comments